Welcome to

International Conference on Cellular Immunotherapy and Molecular Medicine
(ICCIMM-2026)

A global academic platform for research, innovation, and collaboration

Organized by

International Academic Research Forum (IARF)

 
Conference Date
23rd - 24th September 2026
 
Conference Location
Lagos , Nigeria
 
Mode of Conference
Hybrid

Conference Session Tracks

Focused research themes driving global academic dialogue and innovation

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

Goals We Support

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 10 SDG 10 — Reduced Inequalities
SDG 11 SDG 11 — Sustainable Cities and Communities
Session Tracks
Track 01
Advancements in Cellular Immunotherapy

This track focuses on the latest breakthroughs in cellular immunotherapy, including novel approaches and technologies. Participants will explore the implications of these advancements for clinical applications and patient outcomes.

Track 02
Molecular Targets in Cancer Therapy

This session will delve into the identification and validation of molecular targets for cancer therapy. Discussions will include the role of these targets in enhancing the efficacy of immunotherapeutic strategies.

Track 03
Engineering Immune Cells for Therapeutic Applications

This track will cover innovative techniques in immune cell engineering, including the development of CAR-T cells and other adoptive cell therapies. Participants will examine the challenges and successes in translating these engineered cells into clinical practice.

Track 04
Immune Modulation Strategies

This session will focus on various immune modulation strategies aimed at enhancing therapeutic responses in diseases. Topics will include the mechanisms of immune checkpoint regulation and their applications in personalized medicine.

Track 05
Immunogenomics and Personalized Medicine

This track will explore the intersection of immunogenomics and personalized medicine, highlighting how genomic insights can inform tailored immunotherapeutic approaches. Discussions will include the potential for biomarker identification in optimizing treatment outcomes.

Track 06
Regenerative Medicine and Immune Responses

This session will investigate the relationship between regenerative medicine and immune responses, focusing on how cellular therapies can modulate immune activity. Participants will discuss the implications for tissue repair and regeneration.

Track 07
Therapeutic Strategies in Immune Engineering

This track will highlight cutting-edge therapeutic strategies in immune engineering, including novel drug delivery systems and combination therapies. The focus will be on enhancing the efficacy and specificity of immune interventions.

Track 08
Molecular Diagnostics in Immunotherapy

This session will address the role of molecular diagnostics in the field of immunotherapy, emphasizing the importance of accurate biomarker identification. Participants will explore how diagnostics can guide treatment decisions and improve patient outcomes.

Track 09
Targeted Immunotherapy Approaches

This track will focus on the development and application of targeted immunotherapy approaches in various disease contexts. Discussions will include the mechanisms of action and clinical efficacy of these targeted strategies.

Track 10
Immune Response Pathways in Disease

This session will explore the complex immune response pathways involved in various diseases, including cancer and autoimmune disorders. Participants will discuss how understanding these pathways can inform therapeutic interventions.

Track 11
Future Directions in Cellular Therapy

This track will examine the future directions of cellular therapy, including emerging technologies and novel therapeutic paradigms. Participants will engage in discussions on the potential impact of these innovations on clinical practice.